UNC thinktank engineers immune cells to target brain cancer
Mariava Phillips
A UNC research collaboration is rethinking how they can use biomaterials to boost the body's own immune system to enhance cell-based immunotherapy to fight glioblastoma — one of the most aggressive and treatment-resistant brain cancers known to medicine. The post UNC thinktank engineers immune cells to target brain cancer appeared first on Eshelman School of Pharmacy .